Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 ANI Pharma Acquires Two NDAs from Merck for $75M | Contract Pharma

What are you searching for?

Sign in
Breaking News

ANI Pharma Acquires Two NDAs from Merck for $75M

Adds purified corticotropin gel and corticotropin zinc hydroxide to its portfolio

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

ANI Pharmaceuticals Inc. has completed the acquisition of the NDAs for purified corticotropin gel and corticotropin zinc hydroxide from Merck for $75 million in cash and a percentage of future net sales. The assets were acquired from a Dutch subsidiary of Merck by ANI Pharmaceuticals C.V., a Netherlands-based wholly owned indirect subsidiary of ANI.

Arthur Przybyl, president and chief executive officer, ANI Pharmaceuticals said, “Having now closed the acquisition of the corticotrophin NDAs, we look forward to advancing our re-commercialization plan.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters